Abstract:
Diabetes is a major cause of disability and premature death in Bangladesh. Diabetes diseases are diseases of the blood. Patients may need lifestyle change, medications, surgery or other medical procedures as part of treatment. The objective of the present study is to find out the combination therapy pattern for the treatment of diabetes in Bangladesh. The survey of the study was conducted in Narsingdi diabetic hospital (NDH), situated in Narsingdi, the side city of Bangladesh. Study period was 4 months commencing from February 2015 to May 2015.400 prescriptions of diabetic patients were collected from NDH. Among them number of male patients is 262 (65%) and number of female patients is 138 (35%). Most commonly prescribed drugs were Sitagliptin INN (45%), Linagliptin (32.5%), Metformin Hydrochloride (9%), Glyclajide (35%), Sitagliptin& metformin hydrochloride (40%), Drug International occupied 26% drug market , Beximco Pharmaoccupied 13% drug market , Acme Lab occupied 13% drug market(Daomin), Opsoninpharmaoccupied 10% drug market (met,) Aristropharma occupied (13%) Drug marketed (INN)& others Pharmaceutical Companies occupied 8% drug market. The result of this study focused on the prescription pattern and awareness of the patients. People those who are affected and unaffected from this diabetes disease should be more conscious about this because a little bit negligence may lead to this life threatening disease
Description:
This thesis submitted in partial fulfillment of the requirements for the degree of Masters of Pharmacy (M.Pharm) in East West University, Dhaka, Bangladesh.
